China-Africa cooperation initiatives in malaria control and elimination

Advances in Parasitology

Volumn 86, Issue , 2014, Pages 319-337

  Xia, Zhi Gui ^a,b,c   Wang, Ru Bo ^a,b,c   Wang, Duo Quan ^a,b,c   Feng, Jun ^a,b,c   Zheng, Qi ^a,b,c   Deng, Chang Sheng ^d   Abdulla, Salim ^e   Guan, Ya Yi ^a,b,c   Ding, Wei ^a,b,c   Yao, Jia Wen ^a,b,c   Qian, Ying Jun ^a,b,c   Bosman, Andrea ^f   Newman, Robert David ^f   Ernest, Tambo ^g,h   O'leary, Michael ^f   Xiao, Ning ^a,b,c  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Key Laboratory of Parasite and Vector Biology MOH   (China)

^c WHO Collaborating Centre for Malaria Schistosomiasis and Filariasis   (China)

^d GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g Centre for Sustainable Malaria Control Faculty of Natural and Environmental Science   (South Africa)

^h UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Africa; China; Control; Cooperation; Elimination; Malaria

Indexed keywords

AFRICA; AFRICAN; ARTICLE; CHINA; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DRUG DELIVERY SYSTEM; HEALTH PROGRAM; HUMAN; MALARIA; MALARIA CONTROL; MEDICAL INFORMATION; QUALITY CONTROL; TRADITIONAL MEDICINE; DISEASE ERADICATION; ECONOMICS; INTERNATIONAL COOPERATION; PUBLIC HEALTH; RESEARCH; STANDARDS; TRENDS;

AFRICA; CHINA; DISEASE ERADICATION; HUMANS; INTERNATIONAL COOPERATION; MALARIA; NATIONAL HEALTH PROGRAMS; RESEARCH;

EID: 84919473075     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800869-0.00012-3     Document Type: Chapter

References (44)

1. Addae-Mensah I., Fakorede F., Holtel A., Nwaka S. Traditional medicines as a mechanism for driving research innovation in Africa. Malar. J. 2011, 10(Suppl. 1):S9.
2. Agomo C.O., Oyibo W.A. Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria. Infect. Dis. Poverty 2013, 2:19.
3. Aidoo M. Factoring quality laboratory diagnosis into the malaria control agenda for sub-Saharan Africa. Am. J. Trop. Med. Hyg. 2013, 89:403-406.
4. Ajayi I.O., Jegede A.S., Falade C.O., Sommerfeld J. Assessing resources for implementing a community directed intervention (CDI) strategy in delivering multiple health interventions in urban poor communities in Southwestern Nigeria: a qualitative study. Infect. Dis. Poverty 2013, 2:25.
5. Ako B.A., Offianan A.T., Johansson M., Penali L.K., Nguetta S.P., Sibley C.H. Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Cote-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005. Infect. Drug. Resist 2012, 5:113-120.
6. Bhutta Z.A., Sommerfeld J., Lassi Z.S., Salam R.A., Das J.K. Global burden, distribution, and interventions for infectious diseases of poverty. Infect. Dis. Poverty 2014, 3:21.
7. Bi Y., Tong S. Poverty and malaria in the Yunnan province, China. Infect. Dis. Poverty 2014, 3:32.
8. Butler C.D. Infectious disease emergence and global change: thinking systemically in a shrinking world. Infect. Dis. Poverty 2012, 1:5.
9. Chen C. Development of antimalarial drugs and their application in China: a historical review. Infect. Dis. Poverty 2014, 3:9.
10. Chima R.I., Goodman C.A., Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 2003, 63:17-36.
11. Chinese Medical Cooperation in Africa, 2011. Nordiska Afrikainstitut, Uppsala. http://nai.diva-portal.org/smash/get/diva2:399727/FULLTEXT02.
12. Dawson A., Brodie P., Copeland F., Rumsey M., Homer C. Collaborative approaches towards building midwifery capacity in low income countries: a review of experiences. Midwifery 2014, 30(4):391-402.
13. Frosch A.E., Venkatesan P.M., Laufer M.K. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malar. J. 2011, 10:116.
14. Guinovart C., Navia M.M., Tanner M., Alonso P.L. Malaria: burden of disease. Curr. Mol. Med. 2006, 6:137-140.
15. Helmstadter A., Staiger C. Traditional use of medicinal agents: a valid source of evidence. Drug Discov. Today 2013, 19:4-7.
16. Hill J., Hoyt J., van Eijk A.M., D'Mello-Guyett L., Ter Kuile F.O., Steketee R., Smith H., Webster J. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013, 10:e1001488.
17. Liu D.Q. Surveillance of antimalarial drug resistance in China in the 1980s-1990s. Infect. Dis. Poverty 2014, 3:8.
18. Malaria in Africa. http://www.rollbackmalaria.org/cmc_upload/0/000/015/370/RBMInfosheet_3.htm.
19. Mboya-Okeyo T., Ridley R.G., Nwaka S. The african network for drugs and diagnostics innovation. Lancet 2009, 373:1507-1508.
20. Action Plan of China Malaria Elimination (2010-2020). http://www.nhfpc.gov.cn/cmsresources/mohjbyfkzj/cmsrsdocument/doc8571.doc.
21. Noor A.M., Amin A.A., Akhwale W.S., Snow R.W. Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children. PLoS Med. 2007, 4:e255.
22. Nwaka S., Ilunga T.B., Da Silva J.S., Rial Verde E., Hackley D., De Vre R., Mboya-Okeyo T., Ridley R.G. Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med. 2010, 7:e1000293.
23. Odonne G., Berger F., Stien D., Grenand P., Bourdy G. Treatment of leishmaniasis in the Oyapock basin (French Guiana): a K.A.P. survey and analysis of the evolution of phytotherapy knowledge amongst Wayapi Indians. J. Ethnopharmacol. 2011, 137:1228-1239.
24. Pell C., Straus L., Andrew E.V., Menaca A., Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One 2011, 6:e22452.
25. Pohlit A.M., Lima R.B., Frausin G., Silva L.F., Lopes S.C., Moraes C.B., Cravo P., Lacerda M.V., Siqueira A.M., Freitas-Junior L.H., Costa F.T. Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads. Molecules 2013, 18:9219-9240.
26. Sa J.M., Chong J.L., Wellems T.E. Malaria drug resistance: new observations and developments. Essays Biochem. 2011, 51:137-160.
27. Sambo L.G., Ki-Zerbo G., Kirigia J.M. Malaria control in the African Region: perceptions and viewspoints on proceedings of the Africa Leaders Malaria Alliance (ALMA). BMC Proc. 2011, 5(Suppl. 5):S3.
28. Sridaran S., McClintock S.K., Syphard L.M., Herman K.M., Barnwell J.W., Udhayakumar V. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar. J. 2010, 9:247.
29. Tambo E., Adedeji A.A., Huang F., Chen J.H., Zhou S.S., Tang L.H. Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People's Republic of China. Infect. Dis. Poverty 2012, 1:7.
30. Tambo E., Ai L., Zhou X., Chen J.H., Hu W., Bergquist R., Guo J.G., Utzinger J., Tanner M., Zhou X.N. Surveillance-response systems: the key to elimination of tropical diseases. Infect. Dis. Poverty 2014, 3:17.
31. Tambo E., Ugwu E.C., Ngogang J.Y. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect. Dis. Poverty 2014, 3:29.
32. Tang L.H. Chinese achievements in malaria control and research. Chin. J. Parasitol. Parastic. Dis. 1999, 17:3. (in Chinese).
33. Tang L.H. Malaria in China: from control to elimination. Int. Med. Parasitic. Dis. 2009, 36:8. (in Chinese).
34. Thorsteinsdottir H., Melon C.C., Ray M., Chakkalackal S., Li M., Cooper J.E., Chadder J., Saenz T.W., Paula M.C., Ke W., et al. South-South entrepreneurial collaboration in health biotech. Nat. Biotechnol. 2010, 28:407-416.
35. Uwimana J., Zarowsky C., Hausler H., Jackson D. Engagement of non-government organisations and community care workers in collaborative TB/HIV activities including prevention of mother to child transmission in South Africa: opportunities and challenges. BMC Health Serv. Res. 2012, 12:233.
36. Global Plan for Insecticide Resistance Management in Malaria Vectors (GPIRM) 2012, WHO, World Health Organization, Geneva.
37. Test, Treat, Track: Scaling up the Fight against Malaria 2012, WHO, World Health Organization, Geneva.
38. Wang X.Y. Chinese achivements and challenges in aid to africa. Int. Res. Ref. 2013, 7:6. (in Chinese).
39. World Malaria Report 2013 2013, WHO, World Health Organization, Geneva.
40. Yang W., Li Z., Lan Y., Wang J., Ma J., Jin L., Sun Q., Lv W., Lai S., Liao Y., Hu W. A nationwide web-based automated system for outbreak early detection and rapid response in China. Western Pac. Surveill. Response J 2011, 2:10-15.
41. Yin J.H., Yang M.N., Zhou S.S., Wang Y., Feng J., Xia Z.G. Changing malaria transmission and implications in China towards National Malaria Elimination Programme between 2010 and 2012. PLoS One 2013, 8:e74228.
42. Zofou D., Ntie-Kang F., Sippl W., Efange S.M. Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV. Nat. Prod. Rep. 2013, 30:1098-1120.
43. Zofou D., Nyasa R.B., Nsagha D.S., Ntie-Kang F., Meriki H.D., Assob J.C., Kuete V. Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements. Infect. Dis. Poverty 2014, 3:1.
44. Zuo Y. Contributions and challenges of chinese Foreign aid medical team. Int. Economic Collaboration 2013, 11:3. (in Chinese).